These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38820974)

  • 1. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
    Fernández-González JF; García-Pedraza JÁ; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
    Biomed Pharmacother; 2024 Jul; 176():116814. PubMed ID: 38820974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats.
    Fernández-González JF; García-Pedraza JÁ; Marín-Quílez A; Bastida JM; Martín ML; Morán A; García-Domingo M
    Biomed Pharmacother; 2022 Sep; 153():113276. PubMed ID: 35717784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
    García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
    Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic 5-HT
    García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
    Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT
    Fernández-González JF; García-Pedraza JÁ; Ordóñez JL; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of 5-HT
    Hernández-Abreu OI; García-Pedraza JÁ; Rivera-Mancilla E; Villanueva-Castillo B; Morán A; García-Domingo M; Manrique-Maldonado G; Altamirano-Espinoza AH; Villalón CM
    Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):403-411. PubMed ID: 31846086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes.
    García-Pedraza JÁ; Fernández-González JF; López C; Martín ML; Alarcón-Torrecillas C; Rodríguez-Barbero A; Morán A; García-Domingo M
    Life Sci; 2022 Mar; 293():120335. PubMed ID: 35051421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment.
    García-Pedraza JÁ; López C; Fernández-González JF; Martín ML; Morán A; García-Domingo M
    J Pharmacol Sci; 2021 Sep; 147(1):48-57. PubMed ID: 34294372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
    García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
    Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
    García-Pedraza JÁ; García M; Martín ML; Morán A
    Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic activity of sarpogrelate and dopamine D
    Fouad Shalaby MA; Abd El Latif HA; El Yamani M; Galal MA; Kamal S; Sindi I; Masaood R
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):64. PubMed ID: 34702339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
    Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
    García-Pedraza JÁ; García M; Martín ML; San Román L; Morán A
    Eur J Pharmacol; 2014 May; 731():80-7. PubMed ID: 24675150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia.
    García-Pedraza JÁ; García M; Martín ML; Eleno N; Morán A
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):13-22. PubMed ID: 27676327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT
    García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Rodríguez-Barbero A; Martín ML; Morán A
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1224-1231. PubMed ID: 28771848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.
    García M; Morán A; Calama E; Martín ML; Barthelmebs M; Román LS
    Br J Pharmacol; 2005 Jul; 145(5):593-601. PubMed ID: 15852039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
    Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
    Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of peripheral 5-HT
    García-Pedraza JÁ; Hernández-Abreu O; Morán A; Carretero J; García-Domingo M; Villalón CM
    Sci Rep; 2020 Nov; 10(1):19358. PubMed ID: 33168874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats.
    García-Domingo M; García-Pedraza JÁ; Fernández-González JF; López C; Martín ML; Morán A
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension exhibits 5-HT
    García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Ruiz-Remolina L; Rodríguez-Barbero A; Martín ML; Morán A
    Hypertens Res; 2019 May; 42(5):618-627. PubMed ID: 30696976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.